![]() |
Leukemia |
Free Subscription
1 Acta Haematol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Leukemia is free of charge.
Venetoclax-based regimen in refractory or relapsed pediatric acute lymphoblastic
leukemia.
Acta Haematol. 2025 Jul 8:1-18. doi: 10.1159/000547080.
PubMed
Abstract available
Impact of Cytogenetic Response to Therapy on Long-Term Survival in Acute Myeloid
Leukemia.
Am J Hematol. 2025 Jul 11. doi: 10.1002/ajh.70000.
PubMed
Abstract available
Tandem CD19/CD22 CAR T-Cell Therapy as First-Line Treatment for Adult Patients
With High-Risk Philadelphia Chromosome Negative B-Cell Acute Lymphoblastic
Leukemia.
Am J Hematol. 2025 Jul 5. doi: 10.1002/ajh.27752.
PubMed
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): 2025 Update on Diagnosis,
Pathophysiology, Risk Assessment, and Management.
Am J Hematol. 2025;100:1408-1422.
PubMed
Abstract available
Cladribine and medium-dose cytarabine intensified busulfan plus cyclophosphamide
conditioning regimen for adults high-risk B-cell acute lymphoblastic leukemia.
Ann Hematol. 2025 Jul 11. doi: 10.1007/s00277-025-06471.
PubMed
Abstract available
Efficacy and safety analysis of different treatment regimens in newly diagnosed
acute promyelocytic leukemia.
Ann Hematol. 2025 Jul 8. doi: 10.1007/s00277-025-06495.
PubMed
Abstract available
Efficacy of combinatorial inhibition of Hedgehog and autophagy pathways on the
survival of AML cell lines.
Biochem Biophys Res Commun. 2025;775:152034.
PubMed
Abstract available
Repositioning miconazole: A novel drug for inducing cell death and
differentiation in myeloid leukemia.
Biochem Pharmacol. 2025 Jul 4:117126. doi: 10.1016/j.bcp.2025.117126.
PubMed
Abstract available
A novel 3-alkenylindol-2-one derivative selectively inhibits the growth of acute
myeloid leukemia via modulation of the MYC-PRMT pathway.
Biochem Pharmacol. 2025;240:117111.
PubMed
Abstract available
Doubling down: the new deal in the clinical management of double-refractory
chronic lymphocytic leukemia.
Blood. 2025;146:145-154.
PubMed
Abstract available
Paediatric acute myeloid leukaemia epidemiology, treatment approaches, and
outcomes in africa: A review of the literature.
BMC Cancer. 2025;25:1140.
PubMed
Abstract available
Distinct characteristics and social determinants in adult T-cell
leukaemia/lymphoma patients at a tertiary cancer centre in Canada.
Br J Haematol. 2025 May 6. doi: 10.1111/bjh.20132.
PubMed
Abstract available
Ciclosporin A potentiates venetoclax efficacy in FLT3-ITD AML by targeting the
NFATC1-AKT-mTOR-BCL-2/MCL-1 signaling axis.
Br J Haematol. 2025;207:46-58.
PubMed
Abstract available
Genomic variant profiling in blast-phase paediatric chronic myeloid leukaemia:
Predisposing and driving alterations.
Br J Haematol. 2025;207:141-150.
PubMed
Abstract available
Inhibition of DOCK1 suppresses Notch signalling pathway and impairs
leukaemogenesis.
Br J Haematol. 2025;207:59-68.
PubMed
Abstract available
The role of blinatumomab in adult acute B lymphoblastic leukaemia.
Br J Haematol. 2025;207:27-42.
PubMed
Abstract available
CD49d promotes T-cell senescence in chronic lymphocytic leukaemia.
Br J Haematol. 2025;207:80-91.
PubMed
Abstract available
Venetoclax plus azacitidine with or without homoharringtonine followed by
allogeneic haematopoietic cell transplantation in patients with
relapsed/refractory acute myeloid leukaemia: A multicentre cohort study.
Br J Haematol. 2025;207:151-161.
PubMed
Abstract available
Management of chronic myeloid leukemia in 2025.
Cancer. 2025;131:e35953.
PubMed
Abstract available
Immunotherapy in Chronic Lymphocytic Leukemia.
Hematol Oncol Clin North Am. 2025 Jul 8:S0889-8588(25)00082.
PubMed
Abstract available
Frontline Treatment of Chronic Lymphocytic Leukemia with Continuous Bruton's
Tyrosine Kinase Inhibitors: A Comprehensive Overview.
Hematol Oncol Clin North Am. 2025 Jul 7:S0889-8588(25)00078.
PubMed
Abstract available
The Chronic Lymphocytic Leukemia Epigenome: A Powerful and Stable Framework for
Understanding Biological and Clinical Heterogeneity.
Hematol Oncol Clin North Am. 2025 Jul 7:S0889-8588(25)00077.
PubMed
Abstract available
Nelarabine-related rhabdomyolysis in adult patients with T-cell lymphoblastic
leukemia/lymphoma: a report of 6 patients.
Leuk Lymphoma. 2025 Jul 6:1-3. doi: 10.1080/10428194.2025.2521649.
PubMed
Azathioprine as a substitute for 6-mercaptopurine in childhood acute
lymphoblastic leukemia: a single-center retrospective study.
Leuk Lymphoma. 2025 Jul 6:1-9. doi: 10.1080/10428194.2025.2526795.
PubMed
Abstract available
The hallmarks of hematopoietic stem cell transplantation for pediatric acute
myeloid leukemia.
Leukemia. 2025 Jul 9. doi: 10.1038/s41375-025-02685.
PubMed
Abstract available
Chemoresistance of TP53 mutant acute myeloid leukemia requires the mevalonate
byproduct, geranylgeranyl pyrophosphate, for induction of an adaptive stress
response.
Leukemia. 2025 Jul 9. doi: 10.1038/s41375-025-02668.
PubMed
Abstract available
Genomic determinants of therapy response in ETV6::RUNX1 leukemia.
Leukemia. 2025 Jul 9. doi: 10.1038/s41375-025-02683.
PubMed
Abstract available
Cytotoxic activity of Ganoderma weberianum-sichuanese isolated from the Lower
Volta River Basin of Ghana against human prostate carcinoma (PC-3), leukemic T
cell (Jurkat), and plasmacytoid dendritic cell (pDC)-derived acute leukemia
(PMDC05) cell line
PLoS One. 2025;20:e0327087.
PubMed
Abstract available
The WWP1-JARID1B axis sustains acute myeloid leukemia chemoresistance.
Proc Natl Acad Sci U S A. 2025;122:e2421159122.
PubMed
Abstract available
Thank you for your interest in scientific medicine.